Literature DB >> 12952926

CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells.

Andrew P Fontenot1, Laia Gharavi, Sean R Bennett, Scott J Canavera, Lee S Newman, Brian L Kotzin.   

Abstract

T cell receptor engagement with CD28 costimulation is generally required for naive T cell activation, whereas reactivation of memory cells is less dependent on CD28 costimulation. We studied this process in chronic beryllium disease, in which the frequency of antigen-specific CD4+ T cells in the lung is large and circulating antigen-specific cells are also detectable. In the lung, a large fraction of CD4+ T cells stopped expressing CD28 mRNA and protein, and this change in phenotype correlated with lung inflammation. In the presence of concentrations of CTLA-4Ig that inhibited the CD28-B7 interaction, beryllium-specific CD4+ T cells in lung were still able to proliferate and secrete IFN-gamma in response to beryllium in culture. This functional independence of CD28 costimulation included lung CD28+ effector cells. Although lung CD4+CD28- cells retained the ability to secrete Th1-type cytokines in response to beryllium, they showed less proliferative capacity and were more susceptible to cell death compared with CD28+ T cells. In contrast to lung cells, inhibition of the CD28-B7 interaction markedly reduced responses of beryllium-specific T cells in blood. Taken together, these findings suggest transition within memory CD4+ T cells from CD28 dependence in central memory cells to functional independence and then loss of CD28 expression in effector cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12952926      PMCID: PMC182206          DOI: 10.1172/JCI18317

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Functional responses and costimulator dependence of memory CD4+ T cells.

Authors:  C A London; M P Lodge; A K Abbas
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

Review 2.  Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.

Authors:  A P Fontenot; L S Newman; B L Kotzin
Journal:  Clin Immunol       Date:  2001-07       Impact factor: 3.969

3.  Down-regulation of CD28 expression by TNF-alpha.

Authors:  E Bryl; A N Vallejo; C M Weyand; J J Goronzy
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

4.  Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung.

Authors:  Andrew P Fontenot; Lisa A Maier; Scott J Canavera; Tara B Hendry-Hofer; Mark Boguniewicz; Elizabeth A Barker; Lee S Newman; Brian L Kotzin
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

Review 5.  Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.

Authors:  B Salomon; J A Bluestone
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

6.  HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.

Authors:  G Lombardi; C Germain; J Uren; M T Fiorillo; R M du Bois; W Jones-Williams; C Saltini; R Sorrentino; R Lechler
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

7.  Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis.

Authors:  K Katchar; J Wahlström; A Eklund; J Grunewald
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

8.  Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.

Authors:  A P Fontenot; M Torres; W H Marshall; L S Newman; B L Kotzin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

9.  Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease.

Authors:  A P Fontenot; B L Kotzin; C E Comment; L S Newman
Journal:  Am J Respir Cell Mol Biol       Date:  1998-04       Impact factor: 6.914

10.  CD4+CD28- costimulation-independent T cells in multiple sclerosis.

Authors:  S Markovic-Plese; I Cortese; K P Wandinger; H F McFarland; R Martin
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

View more
  26 in total

Review 1.  Chronic beryllium disease: an updated model interaction between innate and acquired immunity.

Authors:  Richard T Sawyer; Lisa A Maier
Journal:  Biometals       Date:  2010-10-28       Impact factor: 2.949

2.  Highly conserved CDR3 region in circulating CD4(+)Vβ5(+) T cells may be associated with cytotoxic activity in Chagas disease.

Authors:  C A S Menezes; A K Sullivan; M T Falta; D G Mack; B M Freed; M O C Rocha; K J Gollob; A P Fontenot; W O Dutra
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

3.  Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.

Authors:  Andrew P Fontenot; Brent E Palmer; Andrew K Sullivan; Fenneke G Joslin; Cara C Wilson; Lisa A Maier; Lee S Newman; Brian L Kotzin
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

4.  Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease.

Authors:  Brent E Palmer; Douglas G Mack; Allison K Martin; May Gillespie; Margaret M Mroz; Lisa A Maier; Andrew P Fontenot
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

5.  CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients.

Authors:  Sean M Studer; M Patricia George; Xuehai Zhu; Yifang Song; Vincent G Valentine; Michael W Stoner; Jigme Sethi; Chad Steele; Steven R Duncan
Journal:  Am J Respir Crit Care Med       Date:  2008-07-10       Impact factor: 21.405

6.  Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression.

Authors:  Allison K Martin; Douglas G Mack; Michael T Falta; Margaret M Mroz; Lee S Newman; Lisa A Maier; Andrew P Fontenot
Journal:  J Allergy Clin Immunol       Date:  2011-09-23       Impact factor: 10.793

7.  Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.

Authors:  Eran Ophir; Noga Or-Geva; Irina Gurevich; Orna Tal; Yaki Eidelstein; Elias Shezen; Raanan Margalit; Assaf Lask; Guy Shakhar; David Hagin; Esther Bachar-Lustig; Shlomit Reich-Zeliger; Andreas Beilhack; Robert Negrin; Yair Reisner
Journal:  Blood       Date:  2012-12-05       Impact factor: 22.113

Review 8.  Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?

Authors:  Vivianne Malmström; Christina Trollmo; Lars Klareskog
Journal:  Arthritis Res Ther       Date:  2005-03-16       Impact factor: 5.156

9.  CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis.

Authors:  Syed R Gilani; Louis J Vuga; Kathleen O Lindell; Kevin F Gibson; Jianmin Xue; Naftali Kaminski; Vincent G Valentine; Emily K Lindsay; M Patricia George; Chad Steele; Steven R Duncan
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

10.  Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon-gamma recovery and reduction of lung injury.

Authors:  V L D Bonato; E D C Gonçalves; E G Soares; R R Santos Júnior; A Sartori; A A M Coelho-Castelo; C L Silva
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.